Skip to main content
. 2022 Dec 30;12(1):297. doi: 10.3390/jcm12010297

Table 1.

Patient characteristics.

Patients, n 64
Age, median (range), y 71 (41–90)
Sex (male: female) 47:17
Primary disease, n
 Pancreatic tumor 15
 Bile duct cancer 10
 Chronic pancreatitis 13
 Bile duct stone 11
 Hepaticojejunostomy stricture 7
 Other 8
Body mass index, median, (range), kg/m2 21.8 (13.0–34.2)
e-GFR, median (range), mL/min 71 (6.57–174)
Mean performance status (±SD) 0.68 ± 0.88
Mean aspartate aminotransferase, (±SD, IU/L) 55.6 ± 75.8
Mean alanine transaminase, (±SD, IU/L) 56.1 ± 98.3
Mean total bilirubin, (±SD, mg/dL) 2.82 ± 5.72
Mean CRP, (±SD, mg/dL) 3.10 ± 5.18
Insomnia before hospitalization, n (%) 8 (12.5)
Regularly taking sleeping drugs, n (%) 7 (10.9)
 Brotizolam 6
Triazolam 1
Lemborexant 0 (0)